A mixture of estrogen hormones used to treat menopause symptoms such as hot flashes and vaginal changes, and to prevent osteoporosis (bone loss) in menopausal women, being also used to replace estrogen in women with ovarian failure or other conditions tha

Novel fluorescent copper probe

Novel potent and selective melanocortin-4 receptor inhibitor, possessing 15-fold selectivity for the MC4R versus the MC3R

Novel positive allosteric modulator of the GABA(B) receptor

Novel positive allosteric modulator of the GABA(B) receptor

Natural potent cytotoxic agent against multiple cancer cell lines, acting on cells as a protein synthesis inhibitor, targeting the eukaryotic translation elongation factor 1A (eEF1A), a target shared by other lipophilic cyclic peptide natural products

Novel photoCORM, exhibiting good cellular uptake and real-time monitoring ability of CO uncaging by a color change approach in cancerous B16F10 cells

Novel class I mutation corrector, rescuing CFTR mutations in nucleotide-binding domain 1 (NBD1) by modulating proteostasis

Selective glucocorticoid receptor antagonist

Preformed water-soluble complex of corticosterone and 2-hydroxypropyl-β-cyclode​xtrin

Inhibitor of Human and Murine CC-Chemokine Receptor 7 Signaling#212121; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: start; text-indent: 0px; text-transform: none; whi

Novel Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis

Novel Potent Mitochondria-Targeted Photodynamic Therapy Anticancer Agent

Novel viral propagation inhibitor, binding to the revised attenuator hairpin structure of the SARS-CoV-2 frameshifting element (FSE), stabilizing the hairpin's folded state and reducing frameshifting efficiency in cells

Potent and selective leukotriene B4 antagonist

Novel potent and selective p38alpha inhibitor

Inhibitor of glycogen phosphorylase; Antidiabetic

Inhibitor of Kv1.3 potassium ion channels

Novel selective α5 GABA A receptor agonist

Novel Mdr1 P-glycoprotein substrate

Potent PPARα agonist with a Ki of 10.8 nM

Novel nonnucleoside reverse transcriptase inhibitor (NNRTI)